Endogen Overview
- Year Founded
-
1983
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$53.6K
Endogen General Information
Description
Manufacturer of biomedical research products intended to investigate the underlying immunological mechanisms of diseases. The company's products include comprehensive lines of cytokine, T cell receptor, cell surface marker, and cell adhesion, enabling the life science industry to research cancer, AIDS, inflammation, and autoimmune disorders.
Contact Information
Website
www.endogen.comCorporate Office
- 8 Gill Street
- Woburn, MA 01801
- United States
Corporate Office
- 8 Gill Street
- Woburn, MA 01801
- United States
Endogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Jan-1999 | $53.6K | Completed | Generating Revenue | ||
| 4. Grant | 01-Jan-1998 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-1997 | Completed | Generating Revenue | |||
| 2. IPO | 18-Sep-1995 | $1.92M | $1.92M | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Endogen Patents
Endogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2423288-A | Elevated il-2 levels as indicators e.g., of allograft rejection | Inactive | 21-Aug-1987 | ||
| EP-0329773-A1 | Elevated il-2 levels as indicators e.g., of allograft rejection | Inactive | 21-Aug-1987 | ||
| EP-0329773-A4 | Elevated il-2 levels as indicators e.g., of allograft rejection | Inactive | 21-Aug-1987 | ||
| CA-1335564-C | Elevated il-2-levels as indicators, e.g. of allograft rejection | Inactive | 21-Aug-1987 | ||
| GB-2220549-B | Interleukin-2(il-2) levels as indicators eg,of allograft rejection,or of the presence or beneficial therapy of treatment for infections or autoimmune diseases | Inactive | 21-Aug-1987 | G01N33/6869 |
Endogen FAQs
-
When was Endogen founded?
Endogen was founded in 1983.
-
Where is Endogen headquartered?
Endogen is headquartered in Woburn, MA.
-
What industry is Endogen in?
Endogen’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Endogen a private or public company?
Endogen is a Private company.
-
What is Endogen’s current revenue?
The current revenue for Endogen is .
-
How much funding has Endogen raised over time?
Endogen has raised $1.92M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process